Alcon presented data on SYSTANE PRO PF at Academy 2026
Alcon announced its participation in Academy 2026 in Anaheim (Sep 30 – Oct 3) and on Oct 1 presented study results showing SYSTANE PRO PF was non‑inferior to MIEBO in relieving dry‑eye symptoms.

ALC Health Care · 1 analysis
Mentioned in recent filings: Ukraine Russia Tariffs Going-concern doubt
Alcon announced its participation in Academy 2026 in Anaheim (Sep 30 – Oct 3) and on Oct 1 presented study results showing SYSTANE PRO PF was non‑inferior to MIEBO in relieving dry‑eye symptoms.
ALCON INC: 12 recorded developments from 5 official sources in 2026-10.
Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.
How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.
| Company | Latest revenue | Revenue YoY | Operating margin |
|---|---|---|---|
| Alcon Inc ALC | — | — | — |
| Unitedhealth Group Inc UNH | $113B | -0.4% | 5.8% |
| Mckesson Corp MCK | $111B | +7.6% | 1.4% |
| CVS Health Corp CVS | $108B | +5.4% | 3.3% |
| Cigna Group CI | $73.7B | +5.6% | 3.3% |
| Cardinal Health Inc CAH | $67.5B | +5.5% | 1.1% |
| Elevance Health, Inc. ELV | $51.4B | +1.4% | 2.5% |
Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.
| Fund | Shares | Value | Change in shares | Quarter |
|---|---|---|---|---|
| Norges Bank (Norway's sovereign fund) | 10,976,697 | $741,431,995 | — | Q2 2026 |
| Fidelity (FMR) | 7,567,130 | $489,960,885 | -1.3% | Q3 2026 |
| D. E. Shaw & Co. | 2,918,650 | $188,982,588 | +57.1% | Q3 2026 |
| Two Sigma Investments | 2,030,060 | $131,446,385 | +346.6% | Q3 2026 |
| Citadel Advisors | 684,878 | $44,345,851 | +73.2% | Q3 2026 |
| BlackRock | 638,773 | $41,360,589 | -1.8% | Q3 2026 |
| Wellington Management | 114,082 | $7,375,467 | +1.4% | Q3 2026 |
| Millennium Management | 106,204 | $6,876,709 | +470.6% | Q3 2026 |
| Bridgewater Associates | 28,891 | $2,176,937 | — | Q1 2026 |
| State Street | 6,123 | $396,464 | 0.0% | Q3 2026 |
From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.